Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data ; volume:11 ; number:3 ; day:2 ; month:5 ; year:2024 ; pages:487-499 ; date:6.2024
Rheumatology and therapy ; 11, Heft 3 (2.5.2024), 487-499, 6.2024
- Urheber
-
Kristensen, Lars Erik
Deodhar, Atul
Leung, Ying-Ying
Vranic, Ivana
Mortezavi, Mahta
Fallon, Lara
Yndestad, Arne
Kinch, Cassandra D.
Gladman, Dafna
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-024-00662-5
- URN
-
urn:nbn:de:101:1-2408011354212.865058119708
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
07.08.2025, 04:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kristensen, Lars Erik
- Deodhar, Atul
- Leung, Ying-Ying
- Vranic, Ivana
- Mortezavi, Mahta
- Fallon, Lara
- Yndestad, Arne
- Kinch, Cassandra D.
- Gladman, Dafna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis
Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis exhibiting further common ground with ankylosing spondylitis.
Autoimmune inner ear disease associated with ankylosing spondylitis
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study
A Novel Qualitative Study Assessing Patient-Reported Outcome Measures Among People Living with Psoriatic Arthritis or Ankylosing Spondylitis
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis
Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis exhibiting further common ground with ankylosing spondylitis.
Autoimmune inner ear disease associated with ankylosing spondylitis
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study
A Novel Qualitative Study Assessing Patient-Reported Outcome Measures Among People Living with Psoriatic Arthritis or Ankylosing Spondylitis
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis
Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis exhibiting further common ground with ankylosing spondylitis.
Autoimmune inner ear disease associated with ankylosing spondylitis
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study